Chinese Science Bulletin

, Volume 44, Issue 18, pp 1655–1659 | Cite as

Synthesis, structure-activity relationship of nociceptin and its fragments

  • Shouliang Dong
  • Tao Wang
  • Qiang Chen
  • Rui Wang


Nociceptin (NC) and its 4 fragments have been synthesized by solid phase peptide synthesis. Their hypotensive activity and mechanism, MVD assay and structure-activity relationship have been investigated. Results show that NC(1–13)NH2 is the smallest fragment that shares the same activity with NC. The truncation of C-terminal not only leads the decrease of receptor affinity but also the changes of receptor selectivity. The entire sequence may not be required for the full activity since NC(1–13)NH2 is as active as NC. Arg-Lys at the 12–13 position of C-terminal plays an important role in the activity of NC. The hypotensive activity of NC does not antagonize the hypertensive activity of renin-angiotensin system.


nociceptin solid phase peptide synthesis hypotensive activity structure-activity relationship 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mollereau, C., Parmentier, M., Mailleux, al., ORL1, a novel member of the opioid receptor family cloning, functional expression and localization,FERS Lett., 1994, 341(1): 33.CrossRefGoogle Scholar
  2. 2.
    Meunier, J.C., Mollereau, C., Toll, al., Isolation and structure of the endogenous agonist of opioid receptor,Nature, 1995, 377(6549): 532.CrossRefGoogle Scholar
  3. 3.
    Reinscheid, K.K., Nothacker, H. P., Bourson, al., Orphanin FQ: A neuropeptide that activates an opioid-like G protein-coupled receptor,Science, 1995, 270(5237): 792.CrossRefGoogle Scholar
  4. 4.
    Tian, J.H., Xu, W., Han, al., Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat,Br. J. Pharmacol., 1997, 120(4): 676.CrossRefGoogle Scholar
  5. 5.
    Champion, H.C., Kadowitz, P.J., Nociceptin, an endogenous ligand for the OKL1 receptor, has novel hypertensive activity in the rat,Life Sci., 1997, 60(16): 241.CrossRefGoogle Scholar
  6. 6.
    Champion, H. C., Kadowitz, P. J., [Tyr1] -nociceptin, a novel nociceptin analog, decreases systemic arterial pressure by a naloxone-insensitive mechanism in the rat,Bwchent. Biophys. Res. Commun., 1997, 234(2): 309.CrossRefGoogle Scholar
  7. 7.
    Wang, R., Hu, X.Y., Jia, al., The design, synthesis, conformation and bioactivity of deltorphins analogues,Chinese Science Bullettin, 1995, 40(16): 1342.Google Scholar
  8. 8.
    Wang, R., Li, X. X., Hu, al., The synthesis, bioactivity and paramagnetic resonance of angiotensin II and its spin labelled derivative,Chinese Science Bullettin, 1997, 42(21): 1843.CrossRefGoogle Scholar
  9. 9.
    Stewart, J.M., Young, J.D.,Solid Phase Peptide Synthesis, 2nd ed, Rockford: Pierce Chemical Company, 1986, 76.Google Scholar
  10. 10.
    Loffit, A., Improvement to the esterification procedure used in solid phase peptide synthesis,Int. J. Protein. Res., 1971, 3(5): 297.Google Scholar
  11. 11.
    Xu, S.Y., Bian, R.L., Chen, X.,Experimental Methodology of Pharmacology, 2nd ed., Beijing: The Peoples Medical Publishing House, 1994, 423–426; 804–807.Google Scholar
  12. 12.
    Berzetei-Gurske, I. P., Schwartz, R. W., Toll, L., Determination of activity for nociceptin in the mouse vas deferens,Eur. J. Pharmacol., 1996, 302(1–3): 1.CrossRefGoogle Scholar

Copyright information

© Science in China Press 1999

Authors and Affiliations

  • Shouliang Dong
    • 1
  • Tao Wang
    • 1
  • Qiang Chen
    • 1
  • Rui Wang
    • 1
  1. 1.Department of Biochemistry and Molecular Biology, School of Life SciencesLanzhou UniversityLanzhouChina

Personalised recommendations